pembrolizumab
merck
['kn-189', 'lcsm,(-blcsm)']
 5-years os update kn-189 5yos: 19.4% vs 11.3% 5ypfs: 7.5% vs 0.6% #esmo22 #lcsm 
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm